Focal adhesion kinase is overexpressed in hepatocellular carcinoma and can be served as an independent prognostic factor

被引:108
|
作者
Fujii, T
Koshikawa, K
Nomoto, S
Okochi, O
Kaneko, T
Inoue, S
Yatabe, Y
Takeda, S
Nakao, A
机构
[1] Nagoya Univ, Dept Surg 2, Grad Sch, Showa Ku, Nagoya, Aichi 4668550, Japan
[2] Nagoya Univ, Fac Med, Showa Ku, Nagoya, Aichi 4668550, Japan
[3] Aichi Canc Ctr Hosp, Dept Pathol & Mol Diagnost, Nagoya, Aichi 464, Japan
关键词
focal adhesion kinase; hepatocellular carcinoma; quantitative RT-PCR; prognostic factor;
D O I
10.1016/j.jhep.2004.03.029
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: The development of human malignancies can be attributed to aberrant regulation of intracellular signal transduction pathways. In the current study, we aimed to evaluate focal adhesion kinase (FAK), a non-receptor tyrosine kinase, expression in hepatocellular carcinoma (HCC), and to explore the prognostic significance of FAK. Methods: We investigated FAK mRNA expression in 60 HCC specimens using quantitative real-time reverse transcription polymerase chain reaction analysis, and the correlation between FAK expression and clinicopathologic parameters. FAK protein expression was examined using Western blot analysis and an immunohistochemical study. Results: We found that FAK mRNA was overexpressed in HCCs compared with the corresponding non-cancerous liver tissues (P = 0.0008). The FAK overexpression correlated significantly with tumor size (P = 0.034) and serum AFP level (P = 0.030). Univariate and multivariate analyses revealed that FAK mRNA expression was an independent prognostic factor for disease-free (risk ratio 3.83; P = 0.024) and overall (risk ratio 7.14; P = 0.015) survival. Besides, we confirmed immunohistochemically that the FAK protein was detectable in cancer cells despite non-expression in corresponding non-cancerous tissues. Conclusions: Our results suggest that FAK mRNA expression has prognostic significance for the survival of patients with HCC. (C) 2004 Published by Elsevier B.V. on behalf of the European Association for the Study of the Liver.
引用
收藏
页码:104 / 111
页数:8
相关论文
共 50 条
  • [31] Focal adhesion kinase confers lenvatinib resistance in hepatocellular carcinoma via the regulation of lysine-deficient kinase 1
    Hou, Wei
    Gad, Shaimaa A.
    Ding, Xianzhong
    Dhanarajan, Asha
    Qiu, Wei
    [J]. MOLECULAR CARCINOGENESIS, 2024, 63 (01) : 173 - 189
  • [32] CRM1, a novel independent prognostic factor overexpressed in invasive breast carcinoma of poor prognosis
    Yue, Lu
    Sun, Zhen-Ni
    Yao, Ya-Sai
    Shen, Zan
    Wang, Hai-Bo
    Liu, Xiang-Ping
    Zhou, Fang
    Xiang, Jin-Yu
    Yao, Ru-Yong
    Niu, Hai-Tao
    [J]. ONCOLOGY LETTERS, 2018, 15 (05) : 7515 - 7522
  • [33] Focal adhesion proteins in hepatocellular carcinoma: RSU1 a novel tumour suppressor with prognostic significance
    Geramoutsou, Christina
    Nikou, Sofia
    Karavias, Dimitrios
    Arbi, Marina
    Tavlas, Panagiotis
    Tzelepi, Vasiliki
    Lygerou, Zoi
    Maroulis, Ioannis
    Bravou, Vasiliki
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2022, 235
  • [34] Focal adhesion kinase expression in invasive breast carcinoma
    Lark, AL
    Livasy, CA
    Millikan, RC
    Dressler, LG
    Cowan, DW
    Tse, J
    Little, DG
    Cance, WG
    [J]. MODERN PATHOLOGY, 2003, 16 (01) : 38A - 38A
  • [35] Can heme oxygenase-1 be a prognostic factor in patients with hepatocellular carcinoma?
    Park, Cheon-Soo
    Eom, Dae-Woon
    Ahn, Yongchel
    Jang, Hyuk Jai
    Hwang, Shin
    Lee, Sung-Gyu
    [J]. MEDICINE, 2019, 98 (26) : e16084
  • [36] Focal adhesion kinase activation limits efficacy of Dasatinib in c-Myc driven hepatocellular carcinoma
    Liu, Xianqiong
    Song, Xhihua
    Zhang, Jie
    Xu, Zhong
    Che, Li
    Qiao, Yu
    Pedraza, Yunuen Ortiz
    Cigliano, Antonio
    Pascale, Rosa M.
    Calvisi, Diego F.
    Liu, Yanju
    Chen, Xin
    [J]. CANCER MEDICINE, 2018, 7 (12): : 6170 - 6181
  • [37] Overexpression of focal adhesion kinase, a protein tyrosine kinase, in ovarian carcinoma
    Judson, PL
    He, XP
    Cance, WG
    Van Le, L
    [J]. CANCER, 1999, 86 (08) : 1551 - 1556
  • [38] PVRIG Expression Is an Independent Prognostic Factor and a New Potential Target for Immunotherapy in Hepatocellular Carcinoma
    Birnbaum, David Jeremie
    Picard, Maelle
    Da Costa, Quentin
    Delayre, Thomas
    Finetti, Pascal
    Cabaud, Olivier
    Agavnian, Emilie
    De Rauglaudre, Bernadette
    Denicolai, Emilie
    Bertucci, Francois
    Mamessier, Emilie
    [J]. CANCERS, 2023, 15 (02)
  • [39] Astrocyte elevated gene-1 overexpression in hepatocellular carcinoma: an independent prognostic factor
    Jung, Hae Il
    Ahn, Taesung
    Bae, Sang Ho
    Chung, Jun Chul
    Kim, Hyungjoo
    Chin, Susie
    Jeong, Dongjun
    Cho, Hyon Doek
    Lee, Moon Soo
    Kim, Hyung Chul
    Kim, Chang Ho
    Baek, Moo-Jun
    [J]. ANNALS OF SURGICAL TREATMENT AND RESEARCH, 2015, 88 (02) : 77 - 85
  • [40] Microvascular tumor embolism: Independent prognostic factor after liver transplantation in hepatocellular carcinoma
    Lee, HH
    Joh, J
    Park, JH
    Lee, KW
    Heo, JS
    Choi, SH
    Kim, SJ
    Lee, SK
    [J]. TRANSPLANTATION PROCEEDINGS, 2005, 37 (02) : 1251 - 1253